AWCT Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
AWCT General Information
Description
Developer of healthcare technology intended to restructure the treatment of diseases and disorders without drugs, implants, or surgery. The company's technology activates innate repair mechanisms in tissue to replace cells and repair damage from wounds and disease, enabling doctors to match the effectiveness of surgery with a non-invasive, minimal-risk treatment.
Contact Information
Website
www.awct.usCorporate Office
- 1633 Old Bayshore Highway
- Suite 125
- Burlingame, CA 94010
- United States
Corporate Office
- 1633 Old Bayshore Highway
- Suite 125
- Burlingame, CA 94010
- United States
AWCT Timeline
AWCT Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-Jun-2025 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series C) | 09-Nov-2023 | Completed | Clinical Trials - General | |||
| 2. Later Stage VC (Series B) | 08-Feb-2019 | $8.21M | $10.1M | Completed | Clinical Trials - General | |
| 1. Early Stage VC (Series A) | 22-May-2017 | $1.88M | $1.88M | Completed | Clinical Trials - General |
AWCT Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C-2 | ||||||||
| Series B | 1,726,659 | $0.000100 | $6.53 | $6.53 | 1x | $6.53 | 13.15% | |
| Series A | 686,111 | $0.000100 | $2.73 | $2.73 | 1x | $2.73 | 7.17% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AWCT Patents
AWCT Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190290305-A1 | Acoustic shockwave apparatus and method | Inactive | 22-Mar-2018 | ||
| AU-2018414535-A1 | Low energy acoustic pulse apparatus and method | Active | 22-Mar-2018 | ||
| AU-2018414535-B2 | Low energy acoustic pulse apparatus and method | Active | 22-Mar-2018 | ||
| CA-3092168-A1 | Low energy acoustic pulse apparatus and method | Pending | 22-Mar-2018 | ||
| EP-3768383-A1 | Low energy acoustic pulse apparatus and method | Pending | 22-Mar-2018 | A61N7/00 |
AWCT Signals
AWCT Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UCSF Innovation Ventures | Venture Capital | Minority | ||
| WI Harper Group | Venture Capital | Minority | ||
| Taiwania Capital Management | Venture Capital | Minority |
AWCT FAQs
-
When was AWCT founded?
AWCT was founded in 2014.
-
Where is AWCT headquartered?
AWCT is headquartered in Burlingame, CA.
-
What is the size of AWCT?
AWCT has 9 total employees.
-
What industry is AWCT in?
AWCT’s primary industry is Therapeutic Devices.
-
Is AWCT a private or public company?
AWCT is a Private company.
-
What is AWCT’s current revenue?
The current revenue for AWCT is .
-
How much funding has AWCT raised over time?
AWCT has raised $20.5M.
-
Who are AWCT’s investors?
UCSF Innovation Ventures, WI Harper Group, and Taiwania Capital Management have invested in AWCT.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process